391 related articles for article (PubMed ID: 25321477)
1. Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.
Liu T; Kishton RJ; Macintyre AN; Gerriets VA; Xiang H; Liu X; Abel ED; Rizzieri D; Locasale JW; Rathmell JC
Cell Death Dis; 2014 Oct; 5(10):e1470. PubMed ID: 25321477
[TBL] [Abstract][Full Text] [Related]
2. Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition.
Coloff JL; Macintyre AN; Nichols AG; Liu T; Gallo CA; Plas DR; Rathmell JC
Cancer Res; 2011 Aug; 71(15):5204-13. PubMed ID: 21670080
[TBL] [Abstract][Full Text] [Related]
3. Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells.
Coloff JL; Mason EF; Altman BJ; Gerriets VA; Liu T; Nichols AN; Zhao Y; Wofford JA; Jacobs SR; Ilkayeva O; Garrison SP; Zambetti GP; Rathmell JC
J Biol Chem; 2011 Feb; 286(7):5921-33. PubMed ID: 21159778
[TBL] [Abstract][Full Text] [Related]
4. Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells.
Mi YJ; Geng GJ; Zou ZZ; Gao J; Luo XY; Liu Y; Li N; Li CL; Chen YQ; Yu XY; Jiang J
PLoS One; 2015; 10(3):e0120426. PubMed ID: 25799586
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells.
Caro-Maldonado A; Wang R; Nichols AG; Kuraoka M; Milasta S; Sun LD; Gavin AL; Abel ED; Kelsoe G; Green DR; Rathmell JC
J Immunol; 2014 Apr; 192(8):3626-36. PubMed ID: 24616478
[TBL] [Abstract][Full Text] [Related]
6. ENO2 Promotes Cell Proliferation, Glycolysis, and Glucocorticoid-Resistance in Acute Lymphoblastic Leukemia.
Liu CC; Wang H; Wang WD; Wang L; Liu WJ; Wang JH; Geng QR; Lu Y
Cell Physiol Biochem; 2018; 46(4):1525-1535. PubMed ID: 29689546
[TBL] [Abstract][Full Text] [Related]
7. Identification of a synergistic combination of dimethylaminoparthenolide and shikonin alters metabolism and inhibits proliferation of pediatric precursor-B cell acute lymphoblastic leukemia.
Sweeney SR; Collins M; Pandey R; Chiou J; Lodi A; Tiziani S
Mol Carcinog; 2020 Apr; 59(4):399-411. PubMed ID: 32027051
[TBL] [Abstract][Full Text] [Related]
8. Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia.
Boag JM; Beesley AH; Firth MJ; Freitas JR; Ford J; Hoffmann K; Cummings AJ; de Klerk NH; Kees UR
Leukemia; 2006 Oct; 20(10):1731-7. PubMed ID: 17041637
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target.
Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB
Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458
[TBL] [Abstract][Full Text] [Related]
10. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K
J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239
[TBL] [Abstract][Full Text] [Related]
11. ATM inhibitor KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose uptake in aggressive cancer cells with sustained activation of Akt.
Harris BRE; Zhang Y; Tao J; Shen R; Zhao X; Cleary MP; Wang T; Yang DQ
FASEB J; 2021 Apr; 35(4):e21264. PubMed ID: 33715230
[TBL] [Abstract][Full Text] [Related]
12. Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis.
Gao P; Shen S; Li X; Liu D; Meng Y; Liu Y; Zhu Y; Zhang J; Luo P; Gu L
Drug Des Devel Ther; 2020; 14():2091-2100. PubMed ID: 32546972
[TBL] [Abstract][Full Text] [Related]
13. The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition.
Brandi J; Cecconi D; Cordani M; Torrens-Mas M; Pacchiana R; Dalla Pozza E; Butera G; Manfredi M; Marengo E; Oliver J; Roca P; Dando I; Donadelli M
Free Radic Biol Med; 2016 Dec; 101():305-316. PubMed ID: 27989750
[TBL] [Abstract][Full Text] [Related]
14. Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming.
Martinez Marignac VL; Smith S; Toban N; Bazile M; Aloyz R
Oncotarget; 2013 Dec; 4(12):2550-66. PubMed ID: 24334291
[TBL] [Abstract][Full Text] [Related]
15. Metabolic phenotype of bladder cancer.
Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
[TBL] [Abstract][Full Text] [Related]
16. Aerobic glycolysis suppresses p53 activity to provide selective protection from apoptosis upon loss of growth signals or inhibition of BCR-Abl.
Mason EF; Zhao Y; Goraksha-Hicks P; Coloff JL; Gannon H; Jones SN; Rathmell JC
Cancer Res; 2010 Oct; 70(20):8066-76. PubMed ID: 20876800
[TBL] [Abstract][Full Text] [Related]
17. TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells.
Straus DS
Mol Cancer; 2013 Jul; 12():78. PubMed ID: 23866118
[TBL] [Abstract][Full Text] [Related]
18. Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis.
Gao C; Yan X; Wang B; Yu L; Han J; Li D; Zheng Q
Sci Rep; 2016 Oct; 6():36114. PubMed ID: 27796318
[TBL] [Abstract][Full Text] [Related]
19. Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation.
Suganuma K; Miwa H; Imai N; Shikami M; Gotou M; Goto M; Mizuno S; Takahashi M; Yamamoto H; Hiramatsu A; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
Leuk Lymphoma; 2010 Nov; 51(11):2112-9. PubMed ID: 20860495
[TBL] [Abstract][Full Text] [Related]
20. Membrane-enriched solute carrier family 2 member 1 (SLC2A1/GLUT1) in psoriatic keratinocytes confers sensitivity to 2-deoxy-D-glucose (2-DG) treatment.
Huang X; Chen J; Zeng W; Wu X; Chen M; Chen X
Exp Dermatol; 2019 Feb; 28(2):198-201. PubMed ID: 30480843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]